163 related articles for article (PubMed ID: 15481852)
21. Evidence that blood ionized calcium can regulate serum 1,25(OH)2D3 independently of parathyroid hormone and phosphorus in the rat.
Bushinsky DA; Riera GS; Favus MJ; Coe FL
J Clin Invest; 1985 Oct; 76(4):1599-604. PubMed ID: 3840495
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
23. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
Tenenhouse HS; Jones G
Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
[TBL] [Abstract][Full Text] [Related]
24. Adaptation of parathyroid function to intravenous 1,25-dihydroxyvitamin D3 or partial parathyroidectomy in normal dogs.
Cloutier M; Gagnon Y; Gascon-Barré M; Brossard JH; D'Amour P
J Endocrinol; 1997 Oct; 155(1):133-41. PubMed ID: 9390015
[TBL] [Abstract][Full Text] [Related]
25. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
[TBL] [Abstract][Full Text] [Related]
26. Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients.
Ben-Ezer D; Shany S; Conforty A; Rapoport J; Edelstein S; Bdolah-Abram T; Kafka DR; Chaimovitz C
Nephron; 1991; 58(3):283-7. PubMed ID: 1896092
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.
Funahashi H; Tanaka Y; Imai T; Wada M; Tsukamura K; Hayakawa Y; Matsuura N; Kikumori T; Oiwa M; Tominaga Y; Takagi H
J Endocrinol Invest; 1998 Jan; 21(1):43-7. PubMed ID: 9633022
[TBL] [Abstract][Full Text] [Related]
28. Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure.
Madsen S; Olgaard K; Ladefoged J
J Clin Endocrinol Metab; 1981 Oct; 53(4):823-7. PubMed ID: 6895227
[TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
Brandi L; Daugaard H; Tvedegaard E; Storm T; Olgaard K
Nephron; 1989; 53(3):194-200. PubMed ID: 2797340
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
31. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma.
Niv Y; Sperber AD; Figer A; Igael D; Shany S; Fraser G; Schwartz B
Cancer; 1999 Aug; 86(3):391-7. PubMed ID: 10430245
[TBL] [Abstract][Full Text] [Related]
32. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women.
Ebeling PR; Sandgren ME; DiMagno EP; Lane AW; DeLuca HF; Riggs BL
J Clin Endocrinol Metab; 1992 Jul; 75(1):176-82. PubMed ID: 1320048
[TBL] [Abstract][Full Text] [Related]
33. 24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure.
Gal-Moscovici A; Rubinger D; Popovtzer MM
Clin Nephrol; 2000 May; 53(5):362-71. PubMed ID: 11305809
[TBL] [Abstract][Full Text] [Related]
34. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis.
Oelzner P; Müller A; Deschner F; Hüller M; Abendroth K; Hein G; Stein G
Calcif Tissue Int; 1998 Mar; 62(3):193-8. PubMed ID: 9501950
[TBL] [Abstract][Full Text] [Related]
35. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
36. In vivo dihydrotachysterol2 metabolism in normal man: 1 alpha- and 1 beta-hydroxylation of 25-hydroxydihydrotachysterol2 and effects on plasma parathyroid hormone and 1 alpha,25-dihydroxyvitamin D3 concentrations.
Schroeder NJ; Trafford DJ; Cunningham J; Jones G; Makin HL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1481-7. PubMed ID: 8200953
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
[TBL] [Abstract][Full Text] [Related]
39. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
40. 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion.
Endo K; Katsumata K; Hirata M; Masaki T; Kubodera N; Nakamura T; Ikeda K; Ogata E
J Bone Miner Res; 2000 Jan; 15(1):175-81. PubMed ID: 10646127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
